PMF™ Diagnostic Device

About Empiriko

Empiriko is a private, preclinical-stage biotech founded in 1993 and based in Cambridge, Massachusetts. The company is pioneering an integrated platform that combines a novel targeted drug delivery system (R*ECL-AI-M™) for radioligand and ADC therapies with a remote diagnostic monitoring device (PMF™). This dual-pronged approach aims to revolutionize personalized cancer treatment by enabling precise therapy delivery and at-home tracking of disease and drug response. Led by an experienced CEO and supported by a distinguished scientific advisory board, Empiriko is positioned at the convergence of targeted radiopharmaceuticals and digital health.

Therapeutic Areas